ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 47 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,503 | -71.1% | 20,223 | -45.0% | 0.00% | – |
| Q1 2022 | $26,000 | -73.2% | 36,794 | -49.8% | 0.00% | – |
| Q4 2021 | $97,000 | +34.7% | 73,332 | +134.0% | 0.00% | – |
| Q3 2021 | $72,000 | -41.0% | 31,335 | +12.7% | 0.00% | – |
| Q2 2021 | $122,000 | -26.9% | 27,805 | +21.2% | 0.00% | – |
| Q1 2021 | $167,000 | -86.7% | 22,943 | -92.1% | 0.00% | – |
| Q4 2020 | $1,260,000 | +425.0% | 291,560 | +399.8% | 0.00% | – |
| Q3 2020 | $240,000 | -76.7% | 58,334 | -66.1% | 0.00% | – |
| Q2 2020 | $1,032,000 | +125.8% | 171,943 | +183.2% | 0.00% | – |
| Q1 2020 | $457,000 | +34.8% | 60,717 | +146.5% | 0.00% | – |
| Q4 2019 | $339,000 | +103.0% | 24,632 | +75.5% | 0.00% | – |
| Q3 2019 | $167,000 | – | 14,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 6,449,856 | $8,514,000 | 2.83% |
| RA Capital Management | 9,694,789 | $12,797,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $9,173,000 | 0.19% |
| HARBOR CAPITAL ADVISORS, INC. | 275,870 | $364,000 | 0.13% |
| Artal Group S.A. | 1,803,858 | $2,381,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 338,756 | $447,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,335,174 | $1,762,000 | 0.05% |
| PVG ASSET MANAGEMENT CORP | 10,000 | $13,200,000 | 0.05% |
| Anson Funds Management LP | 348,266 | $460,000 | 0.04% |
| Eversept Partners, LP | 419,581 | $553,847 | 0.04% |